Simeprevir-13C, d3
Simeprevir-13C, d3 is the 13C- and deuterium labeled Simeprevir. Simeprevir is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses[1][2][5].
Product Specifications
Product Name Alternative
TMC435-13C, d3; TMC435350-13C, d3
UNSPSC
12352005
Target
DNA/RNA Synthesis; HCV; HCV Protease; Isotope-Labeled Compounds; SARS-CoV
Type
Isotope-Labeled Compounds
Related Pathways
Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others
Field of Research
Infection
Solubility
10 mM in DMSO
Smiles
CC1=C(O[13C]([2H])([2H])[2H])C=CC2=C1N=C(C3=NC(C(C)C)=CS3)C=C2O[C@H]4C[C@@H](C(N(C)CCCC/C=C\[C@H](C5)[C@]5(C(NS(=O)(C6CC6)=O)=O)N7)=O)[C@H](C7=O)C4
Molecular Formula
C37 13CH44D3N5O7S2
Molecular Weight
753.95
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
